Cargando…

m(6)A RNA Methylation Regulators Elicit Malignant Progression and Predict Clinical Outcome in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and N6-methyladenosine (m(6)A) is a predominant internal modification of RNA in various cancers. We obtained the expression profiles of m(6)A-related genes for HCC patients from the International Cancer Genome Conso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wenli, Liu, Jun, Ma, Zhanzhong, Zhai, Xiaofeng, Cheng, Binbin, Zhao, Hetong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218914/ https://www.ncbi.nlm.nih.gov/pubmed/34234878 http://dx.doi.org/10.1155/2021/8859590

Ejemplares similares

Identification of key genes and long non-coding RNA associated ceRNA networks in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2019)

Multiple m(6)A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis
por: Qu, Nanfang, et al.
Publicado: (2020)

The Effect of m6A Methylation Regulatory Factors on the Malignant Progression and Clinical Prognosis of Hepatocellular Carcinoma
por: Zhao, Zhongwei, et al.
Publicado: (2020)

An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2020)

A Nomogram Based on a Three-Gene Signature Derived from AATF Coexpressed Genes Predicts Overall Survival of Hepatocellular Carcinoma Patients
por: Liu, Jun, et al.
Publicado: (2020)

Molecular mechanism of m(6)A methylation of circDLC1 mediated by RNA methyltransferase METTL3 in the malignant proliferation of glioma cells
por: Wu, Quansheng, et al.
Publicado: (2022)

Prognostic Power of a Chaperonin Containing TCP-1 Subunit Genes Panel for Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2021)

Screening of potential biomarkers in hepatitis C virus-induced hepatocellular carcinoma using bioinformatic analysis
por: Liu, Jun, et al.
Publicado: (2019)

Effect of m(6)A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma
por: Wang, Jiawu, et al.
Publicado: (2020)

Profiles of m(6)A RNA methylation regulators for the prognosis of hepatocellular carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2019)

Sec62 promotes early recurrence of hepatocellular carcinoma through activating integrinα/CAV1 signalling
por: Du, Juan, et al.
Publicado: (2019)

The Prognostic Significance and Potential Mechanism of Ferroptosis-Related Genes in Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2022)

EPRS1 correlates with malignant progression in hepatocellular carcinoma
por: Yang, Chen, et al.
Publicado: (2023)

Transarterial chemoembolization combined with Jie-du granule preparation improves the survival outcomes of patients with unresectable hepatocellular carcinoma
por: Zhao, Hetong, et al.
Publicado: (2017)

Role of N6-Methyladenosine (m(6)A) Methylation Regulators in Hepatocellular Carcinoma
por: Qu, Nanfang, et al.
Publicado: (2021)

eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway
por: Sun, Liping, et al.
Publicado: (2021)

Landscape of Prognostic m6A RNA Methylation Regulators in Hepatocellular Carcinoma to Aid Immunotherapy
por: Xu, Qianhui, et al.
Publicado: (2021)

N(6)-methyladenosine (m(6)A) RNA methylation regulators are associated with clinical prognosis in hepatocellular carcinoma
por: Li, Gao, et al.
Publicado: (2020)

IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation
por: Cao, Pei, et al.
Publicado: (2022)

METTL3‐mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis
por: Wang, An, et al.
Publicado: (2021)

Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma
por: Li, Wenli, et al.
Publicado: (2020)

PSME4 Activates mTOR Signaling and Promotes the Malignant Progression of Hepatocellular Carcinoma
por: Ge, Sijia, et al.
Publicado: (2022)

Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma
por: Wu, Xiaomin, et al.
Publicado: (2020)

Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
por: Chang, Xian, et al.
Publicado: (2021)

Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival
por: Li, Yong, et al.
Publicado: (2021)

m(6)A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas
por: Chai, Rui-Chao, et al.
Publicado: (2019)

m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer
por: Chen, Mei, et al.
Publicado: (2019)

Exploration of the Role of m(6) A RNA Methylation Regulators in Malignant Progression and Clinical Prognosis of Ovarian Cancer
por: Wei, Qinglv, et al.
Publicado: (2021)

Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma
por: Liu, Jinfang, et al.
Publicado: (2021)

Prognostic Comparison between cTACE and H101-TACE in Unresectable Hepatocellular Carcinoma (HCC): A Propensity-Score Matching Analysis
por: Yao, Man, et al.
Publicado: (2022)

hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner
por: Hao, Weijie, et al.
Publicado: (2023)

Genetic Alterations and Transcriptional Expression of m(6)A RNA Methylation Regulators Drive a Malignant Phenotype and Have Clinical Prognostic Impact in Hepatocellular Carcinoma
por: Zhu, Gui-Qi, et al.
Publicado: (2020)

m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma
por: Li, Fangwei, et al.
Publicado: (2020)

m(6)A RNA Methylation Regulators Contribute to Malignant Progression and Have Clinical Prognostic Impact in Gastric Cancer
por: Su, Yunshu, et al.
Publicado: (2019)

Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma
por: Xu, Fangshi, et al.
Publicado: (2021)

Research Progress of m(6)A RNA Methylation in Skin Diseases
por: Liu, Chang, et al.
Publicado: (2023)

Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma
por: Du, Jianyang, et al.
Publicado: (2020)

N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma
por: Cai, Jihao, et al.
Publicado: (2021)

Expression and significance of m6A-RNA-methylation in oral cancer and precancerous lesion
por: Qin, Zhiming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3j82q93if1tn69bd054nvb6qtc